Search Results

There are 7984 results for: content related to: Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma

  1. From Concept to the Clinics: Development of Novel Large Molecule Cancer Therapeutics

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Balveen Kaur, Gregory B. Lesinski and Abhik Ray Chaudhury

    Published Online : 25 JUN 2010, DOI: 10.1002/9780470571224.pse402

  2. From Concept to the Clinics: Development of Cancer Therapeutics

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Balveen Kaur, Gregory B. Lesinski and Abhik Ray Chaudhary

    Published Online : 16 DEC 2011, DOI: 10.1002/9780470571224.pse421

  3. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines

    International Journal of Laboratory Hematology

    Volume 34, Issue 3, June 2012, Pages: 237–247, B. ZHENG, R. ZHOU, Y. GONG, X. YANG and Q. SHAN

    Article first published online : 7 DEC 2011, DOI: 10.1111/j.1751-553X.2011.01384.x

  4. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A221–A237,

    Article first published online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_1.x

    Corrected by:

    Erratum

    Vol. 13, Issue 2, 335, Article first published online: 17 DEC 2009

  5. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A237–A460,

    Article first published online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_2.x

    Corrected by:

    Erratum

    Vol. 13, Issue 1, 158, Article first published online: 17 DEC 2009

  6. Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells

    Journal of Cellular Physiology

    Volume 216, Issue 3, September 2008, Pages: 698–707, Tina Cascone, Maria Pia Morelli, Floriana Morgillo, Woo-Young Kim, Gabriella Rodolico, Stefano Pepe, Liberato Berrino, Ho-Young Lee, John V. Heymach and Fortunato Ciardiello

    Article first published online : 31 MAR 2008, DOI: 10.1002/jcp.21444

  7. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A250–A480,

    Article first published online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_2.x

  8. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A239–A250,

    Article first published online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_1.x

  9. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage

    Molecular Carcinogenesis

    Volume 52, Issue 2, February 2013, Pages: 118–133, Daniel R. Premkumar, Esther P. Jane, Naomi R. Agostino, Joseph D. DiDomenico and Ian F. Pollack

    Article first published online : 15 NOV 2011, DOI: 10.1002/mc.21835

  10. You have free access to this content
    Monoclonal antibodies in the treatment of multiple myeloma

    British Journal of Haematology

    Volume 154, Issue 6, September 2011, Pages: 745–754, Paul G. Richardson, Sagar Lonial, Andrzej J. Jakubowiak, Jean-Luc Harousseau and Kenneth C. Anderson

    Article first published online : 21 JUL 2011, DOI: 10.1111/j.1365-2141.2011.08790.x

  11. You have free access to this content
    A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas

    Cancer

    Volume 118, Issue 14, 15 July 2012, Pages: 3538–3548, Rajni Sinha, Jonathan L. Kaufman, Hanna Jean Khoury Jr., Nassoma King, Pareen J. Shenoy, Carol Lewis, Kevin Bumpers, Amanda Hutchison-Rzepka, Mourad Tighiouart, Leonard T. Heffner, Mary Jo Lechowicz, Sagar Lonial and Christopher R. Flowers

    Article first published online : 3 JAN 2012, DOI: 10.1002/cncr.26660

  12. Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

    Hematological Oncology

    Volume 31, Issue 4, December 2013, Pages: 179–182, Pier Luigi Zinzani, Cinzia Pellegrini, Emanuela Merla, Filippo Ballerini, Alberto Fabbri, Attilio Guarini, Vincenzo Pavone, Gerlando Quintini, Benedetta Puccini, Maria Luigia Vigliotti, Vittorio Stefoni, Enrico Derenzini, Alessandro Broccoli, Letizia Gandolfi, Federica Quirini, Beatrice Casadei, Lisa Argnani and Michele Baccarani

    Article first published online : 29 OCT 2012, DOI: 10.1002/hon.2036

  13. You have free access to this content
    Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib

    American Journal of Hematology

    Volume 84, Issue 10, October 2009, Pages: 657–660, Raman Sood, Harry Carloss, Robert Kerr, Jose Lopez, Martin Lee, Mark Druck, Ian B. Walters and Stephen J. Noga

    Article first published online : 30 JUL 2009, DOI: 10.1002/ajh.21517

  14. Drug Interaction Between Itraconazole and Bortezomib: Exacerbation of Peripheral Neuropathy and Thrombocytopenia Induced by Bortezomib

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 7, July 2010, Pages: 661–665, Dr. Takuya Iwamoto, Dr. Miki Ishibashi, Dr. Atsushi Fujieda, Dr. Masahiro Masuya, Dr. Naoyuki Katayama and Dr. Masahiro Okuda

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.30.7.661

  15. You have free access to this content
    A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid

    Cancer

    Volume 118, Issue 9, 1 May 2012, Pages: 2507–2515, Manish Sharma, Hassan Khan, Peter F. Thall, Robert Z. Orlowski, Roland L. Bassett Jr., Nina Shah, Qaiser Bashir, Simrit Parmar, Michael Wang, Jatin J. Shah, Chitra M. Hosing, Uday R. Popat, Sergio A. Giralt, Richard E. Champlin and Muzaffar H. Qazilbash

    Article first published online : 1 SEP 2011, DOI: 10.1002/cncr.26517

  16. You have free access to this content
    Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma

    British Journal of Haematology

    Volume 145, Issue 6, June 2009, Pages: 681–708, Sagar Lonial and Jamie Cavenagh

    Article first published online : 17 MAR 2009, DOI: 10.1111/j.1365-2141.2009.07649.x

  17. You have free access to this content
    The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

    Cancer

    Volume 117, Issue 9, 1 May 2011, Pages: 1884–1890, Giulia Benevolo, Alessandra Larocca, Massimo Gentile, Patrizia Pregno, Francesca Gay, Barbara Botto, Chiara Frairia, Andrea Evangelista, Fortunato Morabito, Mario Boccadoro, Umberto Vitolo and Antonio Palumbo

    Article first published online : 18 NOV 2010, DOI: 10.1002/cncr.25743

  18. You have free access to this content
    Proteasome inhibition with bortezomib: A new therapeutic strategy for non-Hodgkin's lymphoma

    International Journal of Cancer

    Volume 119, Issue 5, 1 September 2006, Pages: 971–979, John P. Leonard, Richard R. Furman and Morton Coleman

    Article first published online : 23 MAR 2006, DOI: 10.1002/ijc.21805

  19. You have free access to this content
    Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma

    British Journal of Haematology

    Volume 152, Issue 5, March 2011, Pages: 593–599, Nilanjan Ghosh, Xiaobu Ye, Anna Ferguson, Carol Ann Huff and Ivan Borrello

    Article first published online : 17 JAN 2011, DOI: 10.1111/j.1365-2141.2010.08534.x

  20. Proteasome Inhibition in Nonsmall Cell Lung Cancer Therapy

    Lung Cancer, Third Edition

    Minh Huynh, Primo N. Lara, Pages: 400–410, 2008

    Published Online : 16 APR 2008, DOI: 10.1002/9780470696330.ch25